Medicine Description rimcure-ped- 75gm
Rimcure Ped is a medication that combines pyrazinamide and rifampicin to combat tuberculosis. Pyrazinamide works primarily by disrupting the mycobacterial cell membrane, which interferes with the bacteria's ability to maintain its internal environment, while rifampicin inhibits bacterial RNA synthesis by binding to the DNA-dependent RNA polymerase. Together, these actions effectively halt the growth and replication of Mycobacterium tuberculosis, facilitating the body's immune response to eliminate the infection.
Indications and Uses of Rimcure Ped
- Active pulmonary tuberculosis in pediatric patients
- Extrapulmonary tuberculosis in children
- Part of a comprehensive tuberculosis treatment regimen
Side Effects of Rimcure Ped
- Gastrointestinal disturbances, such as nausea and vomiting
- Rash or hypersensitivity reactions
- Hepatotoxicity, indicated by elevated liver enzymes
- Fatigue and malaise
- Potential for discoloration of bodily fluids (e.g., urine, sweat)
Storage and Handling
Store Rimcure Ped at room temperature, away from moisture and direct sunlight. It should be kept in its original packaging to protect it from environmental factors.
Patient Advice and Precautions
Patients should adhere strictly to the prescribed treatment duration to prevent relapse and avoid the development of drug-resistant tuberculosis. Regular follow-up appointments are essential for monitoring liver function and overall treatment efficacy. Inform healthcare providers of any side effects experienced, especially signs of liver issues or severe allergic reactions. It is important to avoid alcohol consumption during treatment to minimize the risk of liver damage.